🔎 Trials Near Me

Home › Genetic Disorders › NCT06555965

STXBP1 and SYNGAP1 Related Disorders Natural History Study

RecruitingObservational study

STXBP1 and SYNGAP1 Related Disorders (RD) Natural History Study

Who can join

All ages · All sexes

Full eligibility criteria
Inclusion Criteria:

* Male or female of any age.
* Presence of a STXBP1 or SYNGAP1 gene mutation. The variant in STXBP1 or SYNGAP1 must be classified as causative based on clinical and variant classification criteria. Historical documentation is sufficient to support eligibility for the study. Confirmatory testing will be obtained, if necessary, at baseline and performed by a CLIA certified laboratory.

Exclusion Criteria:

* The presence of a confirmed mutation in a gene other than STXBP1 or SYNGAP1 that is known to contribute to a neurodevelopmental disability. This includes full gene deletions of STXBP1 or SYNGAP1 that include other genes beyond STXBP1 or SYNGAP1.
* The presence of a significant non-STXBP1-RD or non-SYNGAP1-RD related central nervous impairment/behavioral disturbance that would confound the scientific rigor or interpretation of results of the study.
* History of intraventricular hemorrhage, structural brain deficit or congenital heart disease
* The presence of a clinical comorbidity deemed by the investigator to potentially confound the typical presentation of STXBP1-RD or SYNGAP1-RD.
* Pregnant women or females of age of menarche who are found to be pregnant upon urine pregnancy testing.

About the study

The purpose of this study is to find out more about STXBP1 and SYNGAP1 related disorders. The information gathered by this study will be used to prepare for clinical treatment trials. The primary objective of the study is to better define and outline the clinical spectrum of STXBP1 and SYNGAP1 through detailed developmental, seizure, and quality of life assessments as an extension of routine clinical care.

What is being tested

Sponsor: Children's Hospital of Philadelphia · Participants: 600 · Started: Aug 30, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06555965

Locations in the U.S.

CaliforniaStanford Medicine Children's Health, Palo Alto
ColoradoChildren's Hospital Colorado, Aurora
New YorkWeill Cornell Medicine, New York
PennsylvaniaThe Children's Hospital of Philadelphia, Philadelphia
TexasTexas Children's Hospital, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.